Clifford Swan Investment Counsel’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,882
Closed -$349K 297
2018
Q3
$349K Sell
8,882
-701
-7% -$31.6K 0.02% 245
2018
Q2
$471K Sell
9,583
-668
-7% -$37.9K 0.03% 212
2018
Q1
$613K Sell
10,251
-1,898
-16% -$127K 0.03% 191
2017
Q4
$956K Sell
12,149
-639
-5% -$51.5K 0.05% 161
2017
Q3
$1.07M Sell
12,788
-1,487
-10% -$105K 0.07% 146
2017
Q2
$933K Sell
14,275
-1,472
-9% -$100K 0.06% 160
2017
Q1
$1.14M Sell
15,747
-1,582
-9% -$104K 0.07% 140
2016
Q4
$1.01M Buy
+17,329
New +$915K 0.07% 144

Other funds holding ADNT

Clifford Swan Investment Counsel's ADNT Position: Q4 2018 in Review

Clifford Swan Investment Counsel sold out of Adient (ADNT) in Q4 2018, closing a stake of 8,882 shares — an estimated $349K sold.

Clifford Swan Investment Counsel first reported a position in ADNT in Q4 2016 and held it in 8 quarters. The position peaked at $1.14M in Q1 2017. 348 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.

  • Clifford Swan Investment Counsel reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
  • Clifford Swan Investment Counsel sold 8,882 Adient shares in Q4 2018, an estimated $349K.
  • Clifford Swan Investment Counsel first reported a position in Adient in Q4 2016 and held it in 8 quarters.
  • Clifford Swan Investment Counsel's Adient position peaked at $1.14M in Q1 2017.
  • 348 funds tracked by Wall St. Rank held Adient as of Q4 2018.

Based on Clifford Swan Investment Counsel's 13F filing for Q4 2018, filed 13 Feb 2019.